Investigating the association between genetically proxied circulating levels of immune checkpoint proteins and cancer survival: protocol for a Mendelian randomisation analysis
Introduction Compared with the traditional drug development pathway, investigating alternative uses for existing drugs (ie, drug repurposing) requires substantially less time, cost and resources. Immune checkpoint inhibitors are licensed for the treatment of certain breast, colorectal, head and neck...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Publishing Group
2024-02-01
|
| Schriftenreihe: | BMJ Open |
| Online-Zugang: | https://bmjopen.bmj.com/content/14/2/e075981.full |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|